Signaling pathway evaluation of leading ATRi, PARPi and CDK7i cancer compounds targeting the DNA Damage Response using Causal Inference
Nina Truter, Wikus Bergh, Martine van den Heever, Shade Horn, Shaw Kj, Dan Leggate, Neil Wilkie, Raminderpal Singh
This paper uses causal inference to evaluate resistance mechanisms of DDR inhibitors in cancer, identifying pathway-specific resistance drivers and potential combination therapies.
bioRxiv · Feb 15, 2024 · PreprintBioinformatics